Inhibition of macrophage phagocytosis by Bacteroides fragilis in vivo and in vitro.
A number of investigators have provided experimental evidence for synergistic effects in mixed infections with Escherichia coli and Bacteroides fragilis. In vitro studies have suggested that competition for serum opsonins and diminished subsequent phagocytosis by polymorphonuclear leukocytes might explain these effects. In the present study we evaluated the effect of B. fragilis on macrophage phagocytosis. It was shown that peritoneal macrophages from mice injected intravenously 6 to 12 h earlier with 10(8) CFU of encapsulated B. fragilis were markedly suppressed in their phagocytic ability. Injections of laboratory-passaged, less-encapsulated B. fragilis, other bacteria, or latex particles were either not suppressive of macrophage phagocytosis or less effective. When peritoneal macrophages were treated in vitro for 24 h with the same challenge organisms prior to assessing their phagocytic capacity, encapsulated B. fragilis also proved significantly more suppressive than challenges with other organisms or latex particles. We conclude that suppression of macrophage phagocytosis by B. fragilis seems to be an important mechanism contributing to synergistic effects described for mixed aerobic and anaerobic infections.
A C
AC
Rodloff
J
J
Becker
D K
DK
Blanchard
T W
TW
Klein
H
H
Hahn
H
H
Friedman
D000818:Animals; D001439:Bacteroides / Q000276:immunology*; D001442:Bacteroides Infections / Q000276:immunology*; D002478:Cells, Cultured; D005260:Female; D008264:Macrophages / Q000276:immunology / Q000502:physiology*; D051379:Mice; D010529:Peritoneal Cavity / Q000166:cytology; D010587:Phagocytosis